Astro-Med, Inc. 10-Q Filing Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Astro-Med, Inc. for the period ended July 30, 2005. The company is a multi-national enterprise designing, developing, and manufacturing data acquisition, storage, and analysis products. Operations are organized into three segments: Test & Measurement (T&M), QuickLabel Systems, and Grass-Telefactor (G-T).
Key Financial Metrics
| Metric | Three Months Ended July 30, 2005 | Six Months Ended July 30, 2005 |
|---|---|---|
| Net Sales | $14,648,202 | $28,841,455 |
| Gross Profit | $6,330,651 (43.2% Margin) | $12,018,974 (41.7% Margin) |
| Operating Income | $904,937 | $1,420,513 |
| Net Income | $621,933 | $1,020,377 |
| Diluted EPS | $0.11 | $0.18 |
| Cash and Equivalents | $2,179,149 (End of Period) | $2,179,149 (End of Period) |
| Operating Cash Flow (6mo) | $544,179 | |
| Total Debt | None reported in current liabilities |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 4.7% in the quarter and 2.1% for the six-month period compared to the prior year. Growth was driven by the QuickLabel (4.5% Q/Q) and G-T (8.4% Q/Q) segments, while T&M sales remained flat.
- Profitability: Net income for the six-month period decreased significantly to $1.02 million from $2.20 million in the prior year. This decline is primarily due to a one-time non-cash tax benefit of $939,000 recognized in the prior year related to the release of a valuation allowance on deferred tax assets.
- Expense Increases: Selling, General, and Administrative (SG&A) expenses rose 9.8% in the quarter and 9.0% for the six months, driven by higher personnel costs, travel, and trade show expenses.
- Cash Flow: Net cash provided by operating activities declined to $544,179 for the six months ended July 30, 2005, from $1.17 million in the prior year, attributed to increased working capital requirements (slower days sales outstanding and inventory turns).
Outlook, Risks, and Unusual Items
- Real Estate Transaction: On June 17, 2005, the company entered an agreement to sell approximately 24.7 acres of land in Braintree, Massachusetts, for $6.1 million. The sale is subject to a 90-day feasibility period and zoning approvals. $250,000 earnest money is currently in escrow.
- Accounting Changes: The company is evaluating the impact of SFAS No. 123(R) regarding share-based payments, which will require fair value measurement of stock options starting in the fiscal year following June 15, 2005.
- Market Risks: Management cites risks including declining demand in defense/aerospace markets (impacting T&M), competition in specialty printing and neurophysiology, and foreign currency exchange rate fluctuations.
- Dividends: The company declared dividends of $0.04 per share for the quarter and $0.08 for the six-month period.
Investor Verification Checklist
- Verify the status and closing conditions of the $6.1 million land sale in Braintree, MA.
- Monitor the impact of the new SFAS No. 123(R) standard on future net income and EPS due to stock-based compensation expensing.
- Assess the sustainability of the T&M segment's flat sales given the noted decline in aerospace orders.
- Review the trend in working capital efficiency, specifically the slowing of inventory turns and days sales outstanding.
- Confirm the exclusion of the $939,000 prior-year tax benefit when comparing year-over-year profitability.